Smith & Nephew plc

Smith & Nephew plc is a British multinational medical technology company specializing in the repair, regeneration, and replacement of soft and hard tissue. Headquartered in Watford, England, it develops and manufactures advanced products across three core business units: Advanced Wound Management for treating chronic and complex wounds; Sports Medicine & ENT for minimally invasive surgical solutions in orthopaedics, arthroscopy, ear, nose, and throat procedures; and Orthopaedics for hip, knee, extremity implants, trauma fixation, and robotics-assisted technologies. Founded in 1856 as a chemist shop in Hull refining cod liver oil, the company pivoted to wound dressings and bandages, expanding globally during World War I and listing on the London Stock Exchange in 1937. Today, with over 18,000 employees, it operates in more than 100 countries, serving hospitals, surgeons, and patients through innovations like PICO negative pressure therapy, JOURNEY II knee implants, OXINIUM joint materials, and CORI Surgical System. Smith & Nephew plc plays a pivotal role in the $50 billion global medtech market, driving advancements in surgical precision, patient recovery, and decentralized care.